GFAP and Alzheimer disease: Analyses of the entorhinal cortex, a fundamental structure for cognitive and memory processes, show that in the triple transgenic mouse model of AD, there is a reduction in primary and secondary branches accompanied by a decrease in volume and area of GFAP expression.